Aliases & Classifications for Stomatitis

MalaCards integrated aliases for Stomatitis:

Name: Stomatitis 12 52 42 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:9637
ICD10 33 K12.1
MeSH 42 D013280
NCIt 47 C26887
UMLS 69 C0038362

Summaries for Stomatitis

MalaCards based summary : Stomatitis is related to hepatitis c virus and aphthous stomatitis, and has symptoms including enanthema, oral manifestations and oral pain. An important gene associated with Stomatitis is LDLR (Low Density Lipoprotein Receptor), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Sucralfate and Morphine have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and t cells, and related phenotypes are Decreased cell number and hematopoietic system

Wikipedia : 72 Stomatitis is inflammation of the mouth and lips. It refers to any inflammatory process affecting the... more...

Related Diseases for Stomatitis

Diseases related to Stomatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 178)
id Related Disease Score Top Affiliating Genes
1 hepatitis c virus 29.1 ADAR BST2 DDX58 EIF2AK2 HNRNPK LDLR
2 aphthous stomatitis 12.3
3 periodic fever, aphthous stomatitis, pharyngitis and adenitis 12.2
4 denture stomatitis 12.1
5 ulcerative stomatitis 12.1
6 sutton disease 2 11.4
7 noma 11.3
8 hand, foot and mouth disease 11.1
9 angular cheilitis 11.1
10 necrotizing ulcerative gingivitis 11.1
11 glucagonoma 11.1
12 methylmalonic aciduria and homocystinuria, cblf type 10.8
13 human monocytic ehrlichiosis 10.6 BST2 DDX58 RSAD2
14 diabetes mellitus, insulin-dependent, 22 10.4 DDX58 IFITM2 IFITM3 RSAD2
15 pharyngitis 10.4
16 non-langerhans-cell histiocytosis 10.4 BST2 DDX58
17 upper lip cancer 10.4 ADAR DDX58 EIF2AK2
18 oral candidiasis 10.3
19 cervicitis 10.2
20 cervical adenitis 10.2
21 hereditary ataxia 10.2 DDX58 EIF2AK2 IFNA2 LDLR
22 eczematous dermatitis of eyelid 10.1 DDX58 EIF2AK2 IFNA2 LDLR
23 enterovesical fistula 10.0 CSF2 CSF3
24 actinomycosis 10.0 DDX58 EIF2AK2 IFITM2 IFITM3 NUP98 RSAD2
25 primary systemic mycosis 10.0 CSF2 CSF3
26 mucositis 10.0
27 influenza 9.9
28 glossitis 9.9
29 hiv-1 9.9
30 lichen planus 9.9
31 neutropenia, severe congenital 3, autosomal recessive 9.9 CSF2 CSF3
32 encephalitis 9.9
33 celiac disease 9.8
34 gingivitis 9.8
35 herpes simplex 9.8
36 neutropenia, severe congenital 1, autosomal dominant 9.8 CSF2 CSF3
37 lymphangiectasia, intestinal 9.8 CSF2 CSF3
38 hepatitis 9.8
39 cheilitis 9.8
40 adenocarcinoma 9.8
41 periodontitis 9.8
42 oral lichen planus 9.8
43 uvulitis 9.8
44 leukemia 9.8
45 vaccinia 9.8
46 pancreatitis 9.8
47 measles 9.8
48 carotid artery dissection 9.8 DDX58 EIF2AK2 IFNA2
49 tonsillitis 9.7
50 prostatitis 9.7

Graphical network of the top 20 diseases related to Stomatitis:



Diseases related to Stomatitis

Symptoms & Phenotypes for Stomatitis

UMLS symptoms related to Stomatitis:


enanthema, oral manifestations, oral pain, burning mucosal, sore roof of mouth (symptom), oral mucosal blisters

GenomeRNAi Phenotypes related to Stomatitis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased cell number GR00303-A 8.92 HNRNPK MTOR NUP98 UBA52

MGI Mouse Phenotypes related to Stomatitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.65 ADAR CSF2 CSF3 DDX58 EIF2AK2 LDLR
2 immune system MP:0005387 9.4 RSAD2 TP63 ADAR CSF2 CSF3 DDX58

Drugs & Therapeutics for Stomatitis

Drugs for Stomatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 405)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Sucralfate Approved Phase 4,Phase 3 54182-58-0
2
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2 57-27-2 5288826
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
4
Nystatin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 1400-61-9 11953884
5
Ephedrine Approved Phase 4,Phase 1,Phase 2 299-42-3 9294
6
Pseudoephedrine Approved Phase 4,Phase 1,Phase 2 90-82-4 7028
7 Castor oil Approved, Vet_approved Phase 4
8
Epinephrine Approved, Vet_approved Phase 4,Phase 1 51-43-4 5816
9 Racepinephrine Approved Phase 4,Phase 1
10
Melphalan Approved Phase 4,Phase 3,Phase 2 148-82-3 4053 460612
11
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2 55-56-1 9552079 2713
12
Ethanol Approved Phase 4,Phase 2,Phase 1 64-17-5 702
13
Hexetidine Approved Phase 4 141-94-6
14
Lenograstim Approved Phase 4,Phase 3,Phase 2 135968-09-1
15
Pemetrexed Approved, Investigational Phase 4 150399-23-8, 137281-23-3 446556 60843
16
Zinc Approved Phase 4,Phase 2,Early Phase 1 7440-66-6 32051 23994
17
Everolimus Approved Phase 4,Phase 3,Phase 2 159351-69-6 6442177
18
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2 53123-88-9 5284616 6436030 46835353
19
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
20
Amifostine Approved, Investigational Phase 4,Phase 2 20537-88-6 2141
21
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 59-30-3 6037
22
leucovorin Approved, Nutraceutical Phase 4,Phase 2,Phase 3,Phase 1 58-05-9 143 6006
23
Vitamin C Approved, Nutraceutical Phase 4,Phase 2,Phase 3 50-81-7 5785 54670067
24
Docetaxel Approved May 1996, Investigational Phase 4,Phase 2 114977-28-5 148124 9877265
25
Methylene blue Investigational Phase 4,Phase 3 61-73-4
26 Antacids Phase 4,Phase 3,Phase 2
27 Anti-Ulcer Agents Phase 4,Phase 3,Phase 2
28 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
29 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
30 Analgesics, Opioid Phase 4,Phase 3,Phase 2,Phase 1
31 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
32 Narcotics Phase 4,Phase 3,Phase 2,Phase 1
33 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
34 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1
35 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
36 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
37 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1
38 Ionophores Phase 4,Phase 3,Phase 2
39 Dermatologic Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
40 Adjuvants, Immunologic Phase 4,Phase 2,Phase 3,Phase 1
41 Antimitotic Agents Phase 4,Phase 2
42
Bilirubin Phase 4,Phase 2 635-65-4 5280352
43 Folic Acid Antagonists Phase 4,Phase 2,Phase 3,Phase 1
44 N-Methylaspartate Phase 4,Phase 2
45 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3
46 Vitamin B Complex Phase 4,Phase 2,Phase 3,Phase 1
47 Micronutrients Phase 4,Phase 2,Phase 3,Phase 1
48 Trace Elements Phase 4,Phase 2,Phase 3,Phase 1
49 Immunosuppressive Agents Phase 4,Phase 2,Phase 3,Phase 1
50 Antirheumatic Agents Phase 4,Phase 2,Phase 3,Phase 1

Interventional clinical trials:

(show top 50) (show all 323)

id Name Status NCT ID Phase Drugs
1 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
2 A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients Completed NCT01283906 Phase 4
3 Topical Morphine for Stomatitis-related Pain Induced by Chemotherapy Completed NCT00357942 Phase 4 morphine solution for injection;Placebo;morphine mouthwash;Placebo
4 Effectiveness of Hygiene Solutions on Denture Biofilm Completed NCT02407834 Phase 4
5 PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation Completed NCT00352703 Phase 4 Kepivance (Palifermin)
6 Photodynamic Therapy Against Candida Spp. in Complete Denture Wearers Completed NCT02642900 Phase 4 Nystatin 100.000 units
7 Hexetidine and Chlorobutanol for Lesions Due to Prostheses Completed NCT01115049 Phase 4 chlorobutanol, hexetidine;Chlorhexidine
8 A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen Completed NCT01107756 Phase 4 LENOGRASTIM (GRANOGYTE 34)
9 Chemotherapy for Patients With Non-Small Cell Lung Cancer Completed NCT00380718 Phase 4 pemetrexed
10 Oral Zinc Therapy for the Prevention of Mucositis Completed NCT00449592 Phase 4 Zinc;Placebo
11 Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients Completed NCT00895583 Phase 4 Tacrolimus;Sirolimus;Tacrolimus
12 Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye Completed NCT01488396 Phase 4 0.05%cyclosporin eye drop
13 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Recruiting NCT01876407 Phase 4
14 Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer Recruiting NCT01707641 Phase 4
15 A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients Recruiting NCT02948699 Phase 4
16 Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older Recruiting NCT02514174 Phase 4 Afatinib
17 G-CSF in the Treatment of Toxic Epidermal Necrolysis Recruiting NCT02739295 Phase 4 recombinant granulocyte - colony stimulating factor;NaCl 0.9%
18 Oral Hygiene Regimen in Patients on HCT Enrolling by invitation NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
19 Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine Suspended NCT01288625 Phase 4 Amifostine
20 Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3) Terminated NCT02695290 Phase 4 Afatinib
21 The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients Unknown status NCT01099891 Phase 3 rhEGF;Placebo
22 Low-energy Laser Therapy for Prevention of Oral Mucositis in Children Unknown status NCT01007617 Phase 2, Phase 3
23 Lactobacillus Brevis CD2 Preventing Oral Mucositis Unknown status NCT02085694 Phase 2, Phase 3 Lactobacillus brevis CD2
24 Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer Unknown status NCT00022373 Phase 3 iseganan HCl oral solution
25 Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation? Unknown status NCT02020928 Phase 3
26 Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation Unknown status NCT02313792 Phase 3 Palifermin
27 Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults Unknown status NCT02173756 Phase 3 morphine gel;placebo gel
28 The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome Unknown status NCT02506231 Phase 2, Phase 3 Folinic acid;Placebo
29 The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus Unknown status NCT01083420 Phase 3 Minocycline;Dexamethasone
30 Traumeel for Post-Tonsillectomy Pain Unknown status NCT00410332 Phase 3 Traumeel S;Placebo
31 COX-2 Inhibitor With Concurrent Chemoradiation in Locally Advanced Head & Neck Carcinoma Unknown status NCT00603759 Phase 3 celecoxib;placebo
32 Prevention of Recurrent Aphthous Stomatitis Using Vitamins Completed NCT00527306 Phase 3
33 Laser for Oral Mucositis in Pediatric Onco-hematology Completed NCT02762019 Phase 3
34 Low-level Laser Therapy on Inflammatory Mediators During Chemotherapy-induced Oral Mucositis Completed NCT02050373 Phase 3
35 Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx Completed NCT00051441 Phase 3 Benzydamine Hydrochloride 0.15% Oral Rinse
36 Clinical Trial on the Efficacy and Safety of Chining Decoction in the Treatment of Radiation Stomatitis Completed NCT02303197 Phase 3 ChiNing decoction
37 Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients Completed NCT01439724 Phase 3
38 Oral Mucositis and Laser Therapy Associated With Photodynamic Therapy Completed NCT02555501 Phase 3
39 Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Completed NCT00101582 Phase 3 Placebo;palifermin;cisplatin chemotherapy
40 Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy Completed NCT02229539 Phase 3 doxepin hydrochloride oral solution;DLA (diphenhydramine, lidocaine and antacids) rinse
41 Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) Completed NCT00109031 Phase 3 palifermin;Cyclophosphamide;Etoposide;Placebo
42 Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer Completed NCT01837446 Phase 2, Phase 3 2% morphine solution;Magnesium aluminum hydroxide;2% viscous lidocaine;Diphenhydramine
43 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer Completed NCT00131638 Phase 3 Placebo;Palifermin
44 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer Completed NCT00393822 Phase 2, Phase 3 palifermin;placebo
45 Curcumin for Prevention of Oral Mucositis in Children Chemotherapy Completed NCT00475683 Phase 3
46 Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy Completed NCT00790322 Phase 3 SBG
47 Caphosol in Oral Mucositis Due to Targeted Therapy Completed NCT01265810 Phase 3
48 A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma Completed NCT00434161 Phase 3 Palifermin before only;Placebo;Palifermin before and after
49 Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy Completed NCT00041665 Phase 3 Recombinant Human Keratinocyte Growth Factor
50 Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation Completed NCT00024037 Phase 2, Phase 3

Search NIH Clinical Center for Stomatitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: stomatitis

Genetic Tests for Stomatitis

Anatomical Context for Stomatitis

MalaCards organs/tissues related to Stomatitis:

39
Bone, Bone Marrow, T Cells, Eye, Lung, Colon, Testes

Publications for Stomatitis

Articles related to Stomatitis:

(show top 50) (show all 1429)
id Title Authors Year
1
Mechanism of membrane fusion induced by vesicular stomatitis virus G protein. ( 27974607 )
2017
2
Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain. ( 28077641 )
2017
3
Recurrent Aphthous Stomatitis: A Review. ( 28360966 )
2017
4
Complete Genome Sequences of Two Vesicular Stomatitis Virus Isolates Collected in Mexico. ( 28912331 )
2017
5
5' -Phospho-RNA acceptor specificity of GDP polyribonucleotidyltransferase of vesicular stomatitis virus in mRNA capping. ( 28053102 )
2017
6
Laboratory-Based Investigation of Denture Sonication Method in Patients with Candida-Associated Denture Stomatitis. ( 28872720 )
2017
7
Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro. ( 28931212 )
2017
8
Association study of interleukin-1 family, interleukin-6, and its receptor gene polymorphisms in patients with recurrent aphthous stomatitis. ( 28543912 )
2017
9
Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (pfapa) syndrome in children. ( 28343210 )
2017
10
INFLUENCE OF OZONE THERAPY ON ORAL TISSUE IN MODELING OF CHRONIC RECURRENT APHTHOUS STOMATITIS. ( 28480862 )
2017
11
The matrix protein of vesicular stomatitis virus inhibits host-directed transcription of target genes via interaction with the TFIIH subunit p8. ( 28888655 )
2017
12
Enzymatic antioxidants status in patients with recurrent aphthous stomatitis. ( 28054386 )
2017
13
Allergic contact stomatitis caused by camphorquinone in a light cure periodontal dressing. ( 28872204 )
2017
14
Unraveling the pathogenesis of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis through genetic, immunologic, and microbiologic discoveries: an update. ( 28557837 )
2017
15
Evolving Frontiers in the Treatment of Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) Syndrome. ( 28786261 )
2017
16
Is chronic ulcerative stomatitis a variant of lichen planus, or a distinct disease? ( 28186659 )
2017
17
Unique histologic features of tonsils from patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. ( 28748511 )
2017
18
Salivary Alpha-Amylase Enzyme, Psychological Disorders, and Life Quality in Patients with Recurrent Aphthous Stomatitis. ( 28408928 )
2017
19
Uremic stomatitis. ( 28062743 )
2017
20
Clinical and Histopathologic Characterization of Canine Chronic Ulcerative Stomatitis. ( 28113036 )
2017
21
Efficacy and safety of Chinese patent medicines in the treatment ofA recurrent aphthous stomatitis: A systematic review. ( 28062049 )
2017
22
Efficacy of Propolis on the Denture Stomatitis Treatment in Older Adults: A Multicentric Randomized Trial. ( 28396692 )
2017
23
Evaluation of Salivary Cortisol Changes and Psychological Profiles in Patients with Recurrent Aphthous Stomatitis. ( 28839413 )
2017
24
Letter regarding "Effect of laser on pain relief and wound healing of recurrent aphthous stomatitis: a systematic review". ( 28801870 )
2017
25
Oral Candida carriage and species prevalence in denture stomatitis patients with and without diabetes. ( 28685534 )
2017
26
Efficacy of photodynamic therapy in the inactivation of oral fungal colonization among cigarette smokers and non-smokers with denture stomatitis. ( 28130176 )
2017
27
In Vitro Evaluation of the Inhibitory Activity of Thymoquinone in Combatting Candida albicans in Denture Stomatitis Prevention. ( 28698449 )
2017
28
Periodic Fever with Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome Is Associated with a CARD8 Variant Unable To Bind the NLRP3 Inflammasome. ( 28137891 )
2017
29
Interleukin-2, Interferon-gamma Gene Polymorphisms in Recurrent Aphthous Stomatitis. ( 28922104 )
2017
30
Stress as a Cause of Recurrent Aphthous Stomatitis and Its Correlation with Salivary Stress Markers. ( 28847142 )
2017
31
Apremilast for treatment of recalcitrant aphthous stomatitis. ( 28884141 )
2017
32
Inhibitory effect of zirconium oxide nanoparticles on Candida albicans adhesion to repaired polymethyl methacrylate denture bases and interim removable prostheses: a new approach for denture stomatitis prevention. ( 28814859 )
2017
33
Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses. ( 28893277 )
2017
34
Aphthous Stomatitis ( 28613713 )
2017
35
Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models. ( 28856238 )
2017
36
Antigastric parietal cell and antithyroid autoantibodies in patients with recurrent aphthous stomatitis. ( 27793414 )
2017
37
Enamel defects and aphthous stomatitis in celiac and healthy subjects: Systematic review and meta-analysis of controlled studies. ( 28688949 )
2017
38
The efficacy of minocycline mouth rinses on the symptoms associated with recurrent aphthous stomatitis: a randomized, double-blind, crossover study assessing different doses of oralA rinse. ( 28411006 )
2017
39
Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients. ( 28381801 )
2017
40
Assessment of Oxidant-Antioxidant Status and Stress Factor in Recurrent Aphthous Stomatitis Patients: Case Control Study. ( 28511497 )
2017
41
Nystatin and disinfectant solutions seem to be effective in treating denture stomatitis. ( 28242007 )
2017
42
Nomalike Necrotizing Stomatitis in a Child with Crohn's Disease. ( 28783211 )
2017
43
Contact stomatitis. ( 28916024 )
2017
44
Investigation of CD40 gene rs4810485 and rs1883832 mutations in patients with recurrent aphthous stomatitis. ( 27875792 )
2017
45
Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective study. ( 28752672 )
2017
46
Angioedema, Stomatitis, and Urticaria Caused by Contact Allergy to Invisalign. ( 28885312 )
2017
47
Leucine-rich repeat-containing G protein-coupled receptor 4 facilitates vesicular stomatitis virus infection by binding vesicular stomatitis virus glycoprotein. ( 28842478 )
2017
48
Physicians' perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome. ( 28271158 )
2017
49
Patient-reported outcome measures in recurrent aphthous stomatitis: A critical assessment of quality properties. ( 28779517 )
2017
50
Phagocytosis and nitric oxide production by peritoneal adherent cells in response to Candida albicans in aging: a collaboration to elucidate the pathogenesis of denture stomatitis. ( 28678945 )
2017

Variations for Stomatitis

Expression for Stomatitis

Search GEO for disease gene expression data for Stomatitis.

Pathways for Stomatitis

Pathways related to Stomatitis according to GeneCards Suite gene sharing:

(show all 11)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.79 ADAR BST2 CSF2 CSF3 DDX58 EIF2AK2
2
Show member pathways
12.88 ADAR BST2 CSF2 CSF3 DDX58 EIF2AK2
3
Show member pathways
12.6 ADAR DDX58 EIF2AK2 HNRNPK IFNA2 NUP98
4 12.04 ADAR EIF2AK2 HNRNPK MTOR
5
Show member pathways
11.97 CSF2 CSF3 IFNA2 MTOR
6
Show member pathways
11.91 ADAR BST2 IFI35 IFITM2 IFITM3 IFNA2
7
Show member pathways
11.85 ADAR BST2 DDX58 EIF2AK2 IFI35 IFITM2
8 11.82 DDX58 EIF2AK2 IFNA2 LDLR
9 11.74 CSF2 CSF3 IFNA2
10
Show member pathways
10.92 ADAR DDX58 EIF2AK2 IFNA2
11 10.76 LDLR MTOR

GO Terms for Stomatitis

Biological processes related to Stomatitis according to GeneCards Suite gene sharing:

(show all 15)
id Name GO ID Score Top Affiliating Genes
1 viral process GO:0016032 9.95 DDX58 EIF2AK2 HNRNPK LDLR NUP98 RSAD2
2 negative regulation of apoptotic process GO:0043066 9.92 ADAR EIF2AK2 HNRNPK TP63 UBA52
3 immune system process GO:0002376 9.91 ADAR DDX58 EIF2AK2 MEFV RSAD2
4 response to virus GO:0009615 9.91 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
5 defense response to virus GO:0051607 9.86 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3
6 response to interferon-gamma GO:0034341 9.71 BST2 IFITM2 IFITM3 MEFV
7 negative regulation of viral entry into host cell GO:0046597 9.63 IFITM2 IFITM3 IFNA2
8 negative regulation of viral genome replication GO:0045071 9.63 ADAR BST2 EIF2AK2 IFITM2 IFITM3 RSAD2
9 response to interferon-beta GO:0035456 9.61 BST2 IFITM2 IFITM3
10 positive regulation of transcription factor import into nucleus GO:0042993 9.55 CSF3 DDX58
11 response to biotic stimulus GO:0009607 9.54 IFITM2 IFITM3
12 response to interferon-alpha GO:0035455 9.35 ADAR BST2 EIF2AK2 IFITM2 IFITM3
13 neutrophil differentiation GO:0030223 9.19 CSF2
14 type I interferon signaling pathway GO:0060337 9.17 ADAR BST2 IFI35 IFITM2 IFITM3 IFNA2
15 innate immune response GO:0045087 10.02 ADAR BST2 DDX58 EIF2AK2 IFITM2 IFITM3

Molecular functions related to Stomatitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.55 ADAR AHSA1 BST2 CSF2 DDX58 EIF2AK2

Sources for Stomatitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....